Results from KEYMAKER-U01 Substudy 3: a Phase 2 Umbrella Study of Pembrolizumab Plus Investigational Agents in Patients with Non-Small-cell Lung Cancer (NSCLC) Previously Treated with Anti-Pd-(l)1 Therapy
CANCER RESEARCH（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined